Stocks › ALHC
Alignment Healthcare ALHC
US equityMarket cap rank #2965
$6.37 −$0.13 (-2.00%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.30 -1.10%
Open$6.55
Prev close$6.50
Day range$6.26 – $6.81
Volume5.00M
Market cap$1.33B
P/E (TTM)46.8
Dividend yield–
Fundamentals
Latest reported quarter: Q3, ended Sep 2026
Revenue$1.36B+36.7% YoY
Operating profit-$3.79M-149.4% YoY
Net profit-$8.05M-315.9% YoY
Diluted EPS-$0.04-300.0% YoY
Free cash flow$38.58M-72.3% YoY
Operating cash flow$47.03M
Revenue, last 8 quarters
Net profit, last 8 quarters
Diluted EPS by quarter
Free cash flow by quarter
Annual revenue
Profitability & balance sheet
Gross margin11.9%
Operating margin0.9%
Net margin0.6%
Return on equity13.2%
Return on assets2.4%
Return on invested capital7.1%
Current ratio1.71
Liabilities / assets78.6%
Cash & investments$742.95M
Total debt$330.70M
Net cash (debt)$412.26M
Free cash flow / sales1.6%
Income statement
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $1.36B | $1.34B | $1.24B | $3.95B | $1.01B |
| Total Operating Revenue | $1.36B | $1.34B | $1.24B | $3.95B | $1.01B |
| Cost of Revenue | $1.22B | $1.15B | $1.09B | $3.46B | $889.49M |
| Gross Profit | $140.69M | $180.96M | $144.48M | $488.56M | $123.31M |
| Operating Expense | $144.48M | $138.86M | $128.98M | $473.81M | $133.59M |
| Selling and Admin Expenses | $136.37M | $131.00M | $121.14M | $443.41M | $125.76M |
| Depreciation & Amortization & Depletion | $8.11M | $7.85M | $7.84M | $30.40M | $7.83M |
| -Depreciation & Amortization | $8.11M | $7.85M | $7.84M | $30.40M | $7.83M |
| Operating Profit | -$3.79M | $42.10M | $15.50M | $14.75M | -$10.28M |
| Net Non-Operating Interest Income (Expense) | -$4.28M | -$4.28M | -$4.06M | -$15.80M | -$3.95M |
| Non-Operating Interest Expense | $4.28M | $4.28M | $4.06M | $15.80M | $3.95M |
| Pretax Profit | -$8.07M | $37.83M | $11.44M | -$958,000.00 | -$14.23M |
| Tax | -$22,000.00 | $1.27M | $25,000.00 | $20,000.00 | -$3.23M |
| Net Profit | -$8.05M | $36.56M | $11.42M | -$978,000.00 | -$11.01M |
| Profit from Continuing Operations | -$8.05M | $36.56M | $11.42M | -$978,000.00 | -$11.01M |
| Minority Interests | $0.00 | $0.00 | $0.00 | -$254,000.00 | $0.00 |
| Net Income to Parent Company | -$8.05M | $36.56M | $11.42M | -$724,000.00 | -$11.01M |
| Net Income to Common Stockholders | -$8.05M | $36.56M | $11.42M | -$724,000.00 | -$11.01M |
| Basic EPS | -$0.04 | $0.18 | $0.06 | $0.00 | -$0.05 |
| Diluted EPS | -$0.04 | $0.17 | $0.05 | $0.00 | -$0.05 |
| Other Income (Expense) | – | $1,000.00 | – | $89,000.00 | $0.00 |
| Other Non-Operating Income (Expenses) | – | $1,000.00 | – | $89,000.00 | $0.00 |
| Special Income (Charges) | – | – | – | $0.00 | – |
Balance sheet
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Total Assets | $1.30B | $1.28B | $1.26B | $1.07B | $1.07B |
| Total Current Assets | $1.18B | $1.16B | $1.15B | $951.58M | $951.58M |
| Cash and Cash Equivalents & Short-Term Investments | $742.95M | $701.71M | $726.29M | $604.23M | $604.23M |
| -Cash and Cash Equivalents | $727.69M | $693.45M | $705.58M | $575.82M | $575.82M |
| -Short Term Investments | $15.26M | $8.26M | $20.71M | $28.41M | $28.41M |
| Receivables | $242.55M | $296.89M | $277.68M | $253.21M | $253.21M |
| -Accounts Receivable | $242.55M | $296.89M | $277.68M | $253.21M | $253.21M |
| Other Current Assets | $192.81M | $161.85M | $141.40M | $94.14M | $94.14M |
| Total Non-Current Assets | $118.56M | $118.59M | $116.24M | $114.21M | $114.21M |
| Net PPE | $73.65M | $73.52M | $70.94M | $71.27M | $71.27M |
| -Gross PPE | $276.55M | $268.33M | $257.89M | $250.40M | $250.40M |
| -Accumulated Depreciation | -$202.91M | -$194.81M | -$186.95M | -$179.13M | -$179.13M |
| Goodwill and Other Intangible Assets | $36.61M | $36.61M | $36.61M | $36.61M | $36.61M |
| -Goodwill | $32.06M | $32.06M | $32.06M | $32.06M | $32.06M |
| -Other Intangible Assets | $4.55M | $4.55M | $4.55M | $4.55M | $4.55M |
| Other Non-Current Assets | $8.30M | $8.46M | $8.69M | $6.33M | $6.33M |
| Total Liabilities | $1.02B | $1.01B | $1.05B | $886.51M | $886.51M |
| Total Current Liabilities | $689.05M | $683.41M | $724.76M | $556.87M | $556.87M |
| Payables | $656.31M | $645.02M | $690.47M | $507.85M | $507.85M |
| -Accounts Payable | $412.34M | $413.76M | $494.42M | $415.74M | $415.74M |
| -Other Payable | $243.97M | $231.26M | $196.05M | $92.12M | $92.12M |
| Total Non-Current Liabilities | $330.70M | $330.50M | $329.97M | $329.64M | $329.64M |
| Long Term Debt and Capital Lease Obligation | $330.70M | $330.50M | $329.97M | $329.64M | $329.64M |
| -Long Term Debt | $324.50M | $324.06M | $323.62M | $323.18M | $323.18M |
| -Long Term Capital Lease Obligation | $6.20M | $6.44M | $6.35M | $6.47M | $6.47M |
| Total Equity | $277.11M | $265.13M | $206.89M | $179.28M | $179.28M |
| Stockholders' Equity | $277.11M | $265.13M | $206.89M | $179.28M | $179.28M |
| Capital Stock | $209,000.00 | $207,000.00 | $207,000.00 | $205,000.00 | $205,000.00 |
| -Common Stock | $209,000.00 | $207,000.00 | $207,000.00 | $205,000.00 | $205,000.00 |
| -Preferred Stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Additional Paid-In Capital | $1.25B | $1.23B | $1.20B | $1.19B | $1.19B |
| Retained Earnings | -$969.09M | -$961.04M | -$997.60M | -$1.01B | -$1.01B |
| Minority Interests | – | – | – | $0.00 | $0.00 |
Cash flow
| Line item | 2026 Q3 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 |
|---|---|---|---|---|---|
| Operating Cash Flow | $47.03M | -$17.31M | $128.68M | $139.93M | -$50.38M |
| Net cash flow from continuing operations | $47.03M | -$17.31M | $128.68M | $139.93M | -$50.38M |
| Net Income from Continuing Operations | -$8.05M | $36.56M | $11.42M | -$978,000.00 | -$11.01M |
| Gain/Loss from Continuing Operations | $0.00 | – | – | -$72,000.00 | $0.00 |
| Depreciation & Depletion & Amortization | $8.12M | $7.86M | $7.86M | $30.48M | $7.83M |
| Other Non-Cash Items | $1.15M | $1.12M | $957,000.00 | $3.37M | $871,000.00 |
| Change in Working Capital | $28.02M | -$81.18M | $94.67M | $45.51M | -$61.22M |
| -Change in Receivables | $53.91M | -$19.48M | -$24.47M | -$100.11M | -$33.66M |
| -Change in Prepaid Assets | -$30.96M | -$20.45M | -$47.26M | -$57.06M | $27.27M |
| -Change in Payables and Accrued Expense | $5.68M | -$40.73M | $166.96M | $204.23M | -$54.32M |
| -Change in Other Current Assets | -$20,000.00 | $27,000.00 | -$16,000.00 | -$50,000.00 | -$3,000.00 |
| -Change in Other Current Liabilities | -$594,000.00 | -$552,000.00 | -$544,000.00 | -$1.50M | -$511,000.00 |
| Net cash flow from investing | -$15.32M | $2.42M | $578,000.00 | -$14.97M | -$7.16M |
| Net Cash Flow from Continuing Investing Activities | -$15.32M | $2.42M | $578,000.00 | -$14.97M | -$7.16M |
| Net PPE Purchase and Sale | -$8.44M | -$10.15M | -$7.36M | -$26.71M | -$5.03M |
| Net Business Purchase and Sale | $0.00 | – | – | $1.07M | $0.00 |
| Net Investment Purchase and Sale | -$6.88M | $12.56M | $7.94M | $10.67M | -$2.13M |
| Financing Cash Flow | $2.55M | $2.77M | $515,000.00 | $18.04M | $15.30M |
| Net Cash Flow from Continuing Financing Activities | $2.55M | $2.77M | $515,000.00 | $18.04M | $15.30M |
| Proceeds from Stock Option Exercised | $2.55M | $3.51M | $2.17M | $18.07M | $15.30M |
| Net Other Financing Charges | $0.00 | -$739,000.00 | -$1.66M | -$26,000.00 | $0.00 |
| Ending Cash Balance | $729.84M | $695.59M | $707.71M | $577.94M | $577.94M |
| Net Change in Cash | $34.25M | -$12.12M | $129.78M | $142.99M | -$42.24M |
| Beginning Cash Balance | $695.59M | $707.71M | $577.94M | $434.94M | $620.18M |
| Free Cash Flow | $38.58M | -$27.46M | $121.32M | $113.15M | -$55.40M |
| Net Issuance Payments Of Debt | – | – | – | $0.00 | $0.00 |
No comments yet — be the first to weigh in on ALHC.
Sign in to join the discussion.